Last updated on 1 Oct 2024
Owner Info
Lennham Pharmaceuticals, Inc.
53 Main Street, Suite 206
Concord MA 01742, UNITED STATES OF AMERICA
Serial Number
2467049 filed on 6 Nov 2023
Correspondent
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue,
Boston MA 02210-2206,
UNITED STATES OF AMERICA
2467049
NA
NA
WORD
5 May 2023
US
Status Date | Action Taken |
---|---|
1st Oct 2024 | International Registration in Australia Protected correspondence sent |
30th Sept 2024 | IP Right Registration Published |
30th Sept 2024 | Status change to Registered/Protected |
24th Jul 2024 | Application Accepted correspondence sent |
23rd Jul 2024 | IP Right has been Examined |
23rd Jul 2024 | IP Right Acceptance Published |
23rd Jul 2024 | Status change to Accepted |
22nd Jul 2024 | Awaiting examination |
22nd Jul 2024 | Examination expedited |
18th Jul 2024 | IP Right Filed Published |